Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990–2019: a modelling study

  12 March 2024

This study examines the prevalence of antimicrobial resistance (AMR) in Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries from 1990 to 2019. The research used a Bayesian spatiotemporal modelling framework to estimate the percentage of MDR, FQNS, and third-generation cephalosporin resistance in these infections. The results showed a decline in MDR in south Asia and southeast Asia, but an increase in FQNS in sub-Saharan Africa. The prevalence of third-generation cephalosporin-resistant S Typhi remained low across the endemic area, except for Pakistan. For S Paratyphi A, the study estimated low prevalence of MDR and third-generation cephalosporin resistance in all endemic countries, but a drastic increase in FQNS. The analysis highlights the increasing levels of AMR in this preventable infection and serves as a resource for urgent public health interventions.

 

Further reading: The Lancet Global Health
Author(s): Gram Typhoid Collaborators
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed